Association of single-nucleotide polymorphism in the FKBP5 gene with response to steroids in pediatric patients with primary nephrotic syndrome

Clinical Nephrology

Volumn 88, Issue 6, 2017, Pages 338-343

  Du, Ni ^a   Yang, Fang ^b   Li, Liangzhi ^a   Liu, Xiaoxiao ^b   Sun, Liangzhong ^c   Zhang, Sui ^b   He, Xianhong ^a   Tang, Yuewu ^a   Shi, Jihong ^a   Liu, Chunqiu ^a   Zhang, Xianxiang ^a  

^a CHONGQING THREE GORGES UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Children; FKBP5 gene; Nephrotic syndrome; Single nucleotide polymorphism

Indexed keywords

FK 506 BINDING PROTEIN; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; STEROID; TRIACYLGLYCEROL; GLUCOCORTICOID; TACROLIMUS BINDING PROTEIN 5;

ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIMARY NEPHROTIC SYNDROME; PROTEIN URINE LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; GENETICS; GENOTYPE; INFANT; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TACROLIMUS BINDING PROTEINS;

EID: 85034217208     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN109126     Document Type: Article

References (26)

1. ISKDC. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978; 13: 159-165.
2. ISKDC. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981; 20: 765-771.
3. Vottero A, Chrousos GP. Glucocorticoid Receptor beta: View I. Trends Endocrinol Metab. 1999; 10: 333-338.
4. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem. 1996; 271: 9550-9559.
5. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest. 1995; 95: 2435-2441.
6. Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol. 2003; 178: 339-346.
7. Chrousos GP, Renquist D, Brandon D, Eil C, Pugeat M, Vigersky R, Cutler GB Jr, Loriaux DL, Lipsett MB. Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. Proc Natl Acad Sci USA. 1982; 79: 2036-2040.
8. Zhang X, Clark AF, Yorio T. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci. 2008; 49: 1037-1047.
9. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000; 141: 4107-4113.
10. Fuller PJ, Smith BJ, Rogerson FM. Cortisol resistance in the New World revisited. Trends Endocrinol Metab. 2004; 15: 296-299.
11. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989; 341: 758-760.
12. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 1989; 341: 755-757.
13. Sinars CR, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J. Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Proc Natl Acad Sci USA. 2003; 100: 868-873.
14. Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol. 1997; 17: 594-603.
15. Barent RL, Nair SC, Carr DC, Ruan Y, Rimerman RA, Fulton J, Zhang Y, Smith DF. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes. Mol Endocrinol. 1998; 12: 342-354.
16. Li L, Lou Z, Wang L. The role of FKBP5 in cancer aetiology and chemoresistance. Br J Cancer. 2011; 104: 19-23.
17. Reynolds PD, Ruan Y, Smith DF, Scammell JG. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J Clin Endocrinol Metab. 1999; 84: 663-669.
18. Vermeer H, Hendriks-Stegeman BI, van Suylekom D, Rijkers GT, van Buul-Offers SC, Jansen M. An in vitro bioassay to determine individual sensitivity to glucocorticoids: induction of FKBP51 mRNA in peripheral blood mononuclear cells. Mol Cell Endocrinol. 2004; 218: 49-55.
19. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA. 2007; 104: 15858-15863.
20. Maltese P, Palma L, Sfara C, de Rocco P, Latiano A, Palmieri O, Corritore G, Annese V, Magnani M. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms. Pharmacogenomics J. 2012; 12: 432-438.
21. Luijk MP, Velders FP, Tharner A, van Ijzendoorn MH, Bakermans-Kranenburg MJ, Jaddoe VW, Hofman A, Verhulst FC, Tiemeier H. FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction. Psychoneuroendocrinology. 2010; 35: 1454-1461.
22. Ising M, Depping AM, Siebertz A, Lucae S, Unschuld PG, Kloiber S, Horstmann S, Uhr M, Müller-Myhsok B, Holsboer F. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci. 2008; 28: 389-398.
23. KDIGO. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl. 2012; 2: 139-274. https://mayoclinic.pure.elsevier.com/en/ publications/kidney-disease-improving-globaloutcomes-kdigo-glomerulonephritis
24. Avellino R, Romano S, Parasole R, Bisogni R, Lamberti A, Poggi V, Venuta S, Romano MF. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood. 2005; 106: 1400-1406.
25. Guo G, Wang H. [Regulative effect of nuclear factor kappa B on the expression of intercellular adhesion molecular-1 in human mesangial cells]. Zhonghua Yi Xue Za Zhi (Taipei). 1998; 78: 290-292.
26. Kidney Disease: Improving Global Outcomes (KIDIGO) Glomerulonephritis Work Group. KIDIGO clinical practice guideline for glomerulonephritis. Chapter 3: Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl. 2011; 2012: 163-171